Following reanalysis, humoral response in patients receiving lenalidomide and dexamethasone was again found to be a highly significant determinant of patient outcome.
1
—
—
Following reanalysis, humoral response in patients receiving lenalidomide and dexamethasone was again found to be a highly significant determinant of patient outcome.